Leukemia & Lymphoma, Volume 58, Issue 10 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 58, Issue 10 (2017)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Volume 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Myeloma patients: genes increase risk for osteonecrosis of the jaw
Melody Becnel & Elisabet Esteve Manasanch
Pages: 2271-2272
Published online: 14 Jun 2017
CitationforMyeloma patients: genes increase risk for osteonecrosis of the jaw | Full Text | References | PDF (247.1 KB) | Supplemental
  • 136 Views
  • 0 CrossRef citations
  • 0Altmetric
Peripheral T-cell lymphomas: very little good, mainly the bad and the ugly
N. Nora Bennani & Stephen M. Ansell
Pages: 2273-2274
Published online: 02 Jun 2017
CitationforPeripheral T-cell lymphomas: very little good, mainly the bad and the ugly | Full Text | References | PDF (251.2 KB)
  • 162 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Novel agents in classical Hodgkin lymphoma
Sven Borchmann & Bastian von Tresckow
Pages: 2275-2286
Published online: 20 Mar 2017
AbstractforNovel agents in classical Hodgkin lymphoma | Full Text | References | PDF (1,023.3 KB) | Supplemental
  • 700 Views
  • 15 CrossRef citations
  • 0Altmetric
The potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia
Andrew Aw & Jennifer R. Brown
Pages: 2287-2297
Published online: 09 May 2017
AbstractforThe potential combination of BCL-2 inhibitors and ibrutinib as frontline therapy in chronic lymphocytic leukemia | Full Text | References | PDF (849.6 KB) | Supplemental
  • 550 Views
  • 8 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Report of the 6th International Workshop on PET in lymphoma
Cristina Nanni, Anne Ségolène Cottereau, Egesta Lopci, Caroline Bodet-Milin, Monica Coronado, Barbara Pro, Wong Seog Kim, Judith Trotman, Sally Barrington, Ulrich Duhrsen, Thierry Vander Borght, Elena Zamagni, Françoise Kraeber-Bodéré, Christina Messiou, Alain Rahmouni, Irène Buvat, Marc Andre, Mark Hertzberg, Wim Oyen, Olivier Casasnovas, Stefano Luminari, Laurent Garderet, Françoise Montravers, Carsten Kobe, Regine Kluge, Annibale Versari, Emanuele Zucca, Philippe Moreau, Bruce Cheson, Corinne Haioun, Andrea Gallamini & Michel Meignan
Pages: 2298-2303
Published online: 07 Mar 2017
AbstractforReport of the 6th International Workshop on PET in lymphoma | Full Text | References | PDF (490.6 KB)
  • 1003 Views
  • 21 CrossRef citations
  • 0Altmetric
Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy
Efstathios Kastritis, Pelagia Melea, Tina Bagratuni, Ioannis Melakopoulos, Maria Gavriatopoulou, Maria Roussou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos & Meletios A. Dimopoulos
Pages: 2304-2309
Published online: 11 Jun 2017
AbstractforGenetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy | Full Text | References | PDF (617.6 KB) | Supplemental
  • 380 Views
  • 16 CrossRef citations
  • 0Altmetric
A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas
Douglas W. Sborov, Alessandro Canella, Erinn M. Hade, Xiaokui Mo, Soun Khountham, Jiang Wang, Wenjun Ni, Ming Poi, Christopher Coss, Zhongfa Liu, Mitch A. Phelps, Amir Mortazavi, Leslie Andritsos, Robert A. Baiocchi, Beth A. Christian, Don M. Benson, Joseph Flynn, Pierluigi Porcu, John C. Byrd, Flavia Pichiorri & Craig C. Hofmeister
Pages: 2310-2318
Published online: 07 Mar 2017
AbstractforA phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas | Full Text | References | PDF (831.5 KB) | Supplemental
  • 660 Views
  • 41 CrossRef citations
  • 0Altmetric
Salvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study
Tanya Skamene, Michael Crump, Kerry J. Savage, Tony Reiman, John Kuruvilla, David Good, David LeBrun, Ralph M. Meyer, Laurie H. Sehn, Denis Soulières, Julie Stakiw, Nicole Laferriere, Stefano Luminari, Lois E. Shepherd, Marina Djurfeldt, Liting Zhu, Bingshu E. Chen & Annette E. Hay
Pages: 2319-2327
Published online: 15 May 2017
AbstractforSalvage chemotherapy and autologous stem cell transplantation for peripheral T-cell lymphoma: a subset analysis of the Canadian Cancer Trials Group LY.12 randomized phase 3 study | Full Text | References | PDF (1.3 MB) | Supplemental
  • 765 Views
  • 16 CrossRef citations
  • 0Altmetric
18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation
Domenico Albano, Giovanni Bosio, Raffaele Giubbini & Francesco Bertagna
Pages: 2328-2334
Published online: 07 Mar 2017
Abstractfor18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation | Full Text | References | PDF (826.4 KB) | Supplemental
  • 223 Views
  • 32 CrossRef citations
  • 0Altmetric
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials
Andrei Shustov, Bertrand Coiffier, Steven Horwitz, Lubomir Sokol, Barbara Pro, Julie Wolfson, Barbara Balser, Robin Eisch, Leslie Popplewell, H. Miles Prince, Steven L. Allen, Richard Piekarz & Susan Bates
Pages: 2335-2341
Published online: 07 Mar 2017
AbstractforRomidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials | Full Text | References | PDF (1.1 MB) | Supplemental
  • 2819 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Accuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma – tissue remains the issue
Anthony Q. Pham, Stephen M. Broski, Thomas M. Habermann, Dragan Jevremovic, Gregory A. Wiseman, Andrew L. Feldman, Matthew J. Maurer, Kay M. Ristow & Thomas E. Witzig
Pages: 2342-2348
Published online: 14 Mar 2017
AbstractforAccuracy of 18-F FDG PET/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma – tissue remains the issue | Full Text | References | PDF (1.6 MB) | Supplemental
  • 208 Views
  • 6 CrossRef citations
  • 0Altmetric
The clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma
Yi Chen, Xiaoyun Zheng, Buyuan Chen, Xiaozhu Yang, Jing Zheng, Zhihong Zheng, Ting Yang, Tingbo Liu & Jianda Hu
Pages: 2349-2355
Published online: 17 Mar 2017
AbstractforThe clinical significance of Epstein-Barr virus DNA in peripheral blood mononuclear cells in patients with non-Hodgkin lymphoma | Full Text | References | PDF (1 MB) | Supplemental
  • 370 Views
  • 12 CrossRef citations
  • 0Altmetric
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
Fie J. Vojdeman, Sarah E. M. Herman, Nikolai Kirkby, Adrian Wiestner, Mars B. van t’ Veer, Geir E. Tjønnfjord, Maija A. Itälä-Remes, Eva Kimby, Mohammed Z. Farooqui, Aaron Polliack, Ka Lung Wu, Jeanette K. Doorduijn, Wendimagegn G. Alemayehu, Shulamiet Wittebol, Tomas Kozak, Jan Walewski, Martine C. J. Abrahamse-Testroote, Marinus H. J. van Oers, Christian H. Geisler & Carsten U. Niemann
Pages: 2356-2362
Published online: 07 Feb 2017
AbstractforSoluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia | Full Text | References | PDF (945.2 KB) | Supplemental
  • 400 Views
  • 6 CrossRef citations
  • 0Altmetric
Osteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia – first findings of the OPAL trial
Kathinka Krull, Marina Kunstreich, Janina Klasen-Sansone, Andreas Kloetgen, Franziska Gruener, Gabriele Escherich, Kirsten Bleckmann, Anja Moericke, Martin Schrappe, Norbert Jorch, Daniel Steinbach, Carl-Friedrich Classen, Andreas Guggemos, Reinhard Kolb, Dirk Klee, Arndt Borkhardt & Michaela Kuhlen
Pages: 2363-2369
Published online: 31 Jan 2017
AbstractforOsteonecrosis develops independently from radiological leukemic infiltration of bone in adolescents with acute lymphoblastic leukemia – first findings of the OPAL trial | Full Text | References | PDF (786 KB) | Supplemental
  • 291 Views
  • 6 CrossRef citations
  • 0Altmetric
A randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia
Etan Orgel, Nicole M. Mueske, Richard Sposto, Vicente Gilsanz, Tishya A. L. Wren, David R. Freyer, Anna M. Butturini & Steven D. Mittelman
Pages: 2370-2378
Published online: 20 Feb 2017
AbstractforA randomized controlled trial testing an adherence-optimized Vitamin D regimen to mitigate bone change in adolescents being treated for acute lymphoblastic leukemia | Full Text | References | PDF (1.4 MB) | Supplemental
  • 381 Views
  • 11 CrossRef citations
  • 0Altmetric
Incidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes
Jason A. Trubiano, Michael Dickinson, Karin A. Thursky, Timothy Spelman, John F. Seymour, Monica A. Slavin & Leon J. Worth
Pages: 2379-2386
Published online: 28 Feb 2017
AbstractforIncidence, etiology and timing of infections following azacitidine therapy for myelodysplastic syndromes | Full Text | References | PDF (799.7 KB) | Supplemental
  • 714 Views
  • 19 CrossRef citations
  • 0Altmetric
Usefulness of the delta neutrophil index as an ancillary test in the emergency department for the early diagnosis of suspected acute promyelocytic leukemia
Dong Ryul Ko, Ji Eun Jang, Sung Phil Chung, Jong Wook Lee, Hye Sun Lee, Jung Hwa Hong, Taeyoung Kong, Je Sung You & Incheol Park
Pages: 2387-2394
Published online: 02 Mar 2017
AbstractforUsefulness of the delta neutrophil index as an ancillary test in the emergency department for the early diagnosis of suspected acute promyelocytic leukemia | Full Text | References | PDF (1.7 MB) | Supplemental
  • 206 Views
  • 4 CrossRef citations
  • 0Altmetric
Surgical treatment of acute abdominal complications in hematology patients: outcomes and prognostic factors
Djamel Mokart, Marion Penalver, Laurent Chow-Chine, Jacques Ewald, Antoine Sannini, Jean Paul Brun, Magali Bisbal, Bernard Lelong, Jean Robert Delpero, Marion Faucher & Olivier Turrini
Pages: 2395-2402
Published online: 28 Feb 2017
AbstractforSurgical treatment of acute abdominal complications in hematology patients: outcomes and prognostic factors | Full Text | References | PDF (721.2 KB) | Supplemental
  • 254 Views
  • 9 CrossRef citations
  • 0Altmetric

Original Articles: Research

Does cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with diffuse large B-cell lymphoma treated with rituximab and chemotherapy? A systematic review
Mia Schmidt-Hansen, Sabine Berendse, Teresa Marafioti & Christopher McNamara
Pages: 2403-2418
Published online: 09 Feb 2017
AbstractforDoes cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with diffuse large B-cell lymphoma treated with rituximab and chemotherapy? A systematic review | Full Text | References | PDF (1.2 MB) | Supplemental
  • 618 Views
  • 12 CrossRef citations
  • 0Altmetric
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia
Maria Giovanna Vilia, Eleonora Fonte, Tania Veliz Rodriguez, Marta Tocchetti, Pamela Ranghetti, Lydia Scarfò, Nikos Papakonstantinou, Stavroula Ntoufa, Kostas Stamatopoulos, Paolo Ghia & Marta Muzio
Pages: 2419-2425
Published online: 28 Feb 2017
AbstractforThe inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemia | Full Text | References | PDF (965.4 KB) | Supplemental
  • 304 Views
  • 7 CrossRef citations
  • 0Altmetric
Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways
Li-Na Wang, Yan-Lai Tang, Yin-Chuan Zhang, Zu-Han Zhang, Xiao-Jian Liu, Zhi-Yong Ke, Yu Li, Hui-Zhen Tan, Li-Bin Huang & Xue-Qun Luo
Pages: 2426-2438
Published online: 09 Mar 2017
AbstractforArsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways | Full Text | References | PDF (2.6 MB) | Supplemental
  • 801 Views
  • 22 CrossRef citations
  • 0Altmetric
Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells
Xiuli Ding, Jiadong Chi, Xue Yang, Jian Hao, Chang Liu, Cuihong Zhu, Xiaodong Wang, Xiaohui Liu, Yangyang Niu, Wei Ji, Dan Chen & Xiongzhi Wu
Pages: 2439-2451
Published online: 20 Feb 2017
AbstractforCucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells | Full Text | References | PDF (2.7 MB) | Supplemental
  • 196 Views
  • 19 CrossRef citations
  • 0Altmetric
The diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis
Li Wang, Lan Luo, Zhe Gao, Shu-Feng Liu, Cheng-Jun Liu, De-Xun Ma, Ji-Gang Chen, Wu-Rui Cao, Ai-Min Yin, Jia-Wen Xu, Song-Lei Wang, Du-Jun Zhuo, Bin Geng, Sha-Sha Zhao, Fei-Yan Wang, Nan Yang, Li-Xun Guan, Zhen-Yang Gu & Chun-Ji Gao
Pages: 2452-2459
Published online: 20 Feb 2017
AbstractforThe diagnostic and prognostic value of interleukin-10 in cerebrospinal fluid for central nervous system lymphoma: a meta-analysis | Full Text | References | PDF (1.4 MB) | Supplemental
  • 217 Views
  • 9 CrossRef citations
  • 0Altmetric
Krüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma
Xin-yu Li, Ling-yun Geng, Xiang-xiang Zhou, Na Wei, Xiao-sheng Fang, Ying Li & Xin Wang
Pages: 2460-2469
Published online: 28 Feb 2017
AbstractforKrüppel-like factor 4 contributes to the pathogenesis of mantle cell lymphoma | Full Text | References | PDF (1.9 MB) | Supplemental
  • 213 Views
  • 4 CrossRef citations
  • 0Altmetric
A novel recurrent copy number loss region on 6q23.3 in MDS-related myeloid malignancy patients with stable survival conditions
Kun Chi, Yang Li, Lan Xu & Xuefeng Wang
Pages: 2470-2479
Published online: 10 Apr 2017
AbstractforA novel recurrent copy number loss region on 6q23.3 in MDS-related myeloid malignancy patients with stable survival conditions | Full Text | References | PDF (1.4 MB) | Supplemental
  • 118 Views
  • 1 CrossRef citations
  • 0Altmetric

Letters to the Editor

MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma
Nuray Akyüz, Nadine Albert-Konetzny, Christiane Pott, Evelyne Callet-Bauchu, Carsten Bokemeyer, Eva Maria Murga Penas & Judith Dierlamm
Pages: 2480-2484
Published online: 02 Mar 2017
First Page PreviewforMALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma | Full Text | References | PDF (974.3 KB) | Supplemental
  • 158 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)
Elżbieta Iskierka-Jażdżewska, Marek Hus, Krzysztof Giannopoulos, Elżbieta Mądro, Jadwiga Hołojda, Magdalena Piotrowska, Jan M. Zaucha, Weronika Piszczek, Agnieszka Szeremet, Małgorzata Wojciechowska, Paweł Steckiewicz, Wanda Knopińska-Posłuszny, Marek Osowiecki, Joanna Drozd-Sokołowska, Beata Kumiega, Sławomira Kyrcz-Krzemień, Janusz Hałka, Marek Dudziński, Paulina Wieszczy, Tadeusz Robak, Krzysztof Warzocha & Krzysztof Jamroziak
Pages: 2485-2488
Published online: 28 Feb 2017
First Page PreviewforEfficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG) | Full Text | References | PDF (465.8 KB) | Supplemental
  • 508 Views
  • 30 CrossRef citations
  • 0Altmetric
Diagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies
Hideo Koh, Satoru Nanno, Takako Katayama, Asao Hirose, Mika Nakamae, Masayuki Hino & Hirohisa Nakamae
Pages: 2489-2492
Published online: 28 Feb 2017
First Page PreviewforDiagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies | Full Text | References | PDF (447.6 KB) | Supplemental
  • 136 Views
  • 3 CrossRef citations
  • 0Altmetric
High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma
Giovanni Bernardini, Elisabetta Vulpis, Valentina Bonanni, Helena Stabile, Maria Rosaria Ricciardi, Maria Teresa Petrucci, Angela Gismondi, Angela Santoni & Alessandra Zingoni
Pages: 2493-2496
Published online: 28 Feb 2017
First Page PreviewforHigh expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma | Full Text | References | PDF (812.3 KB) | Supplemental
  • 414 Views
  • 6 CrossRef citations
  • 0Altmetric
Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, Tajana Stoos-Veic, Gorana Aralica, Iva Gecek, Vlatko Pejsa & Rajko Kusec
Pages: 2497-2500
Published online: 28 Feb 2017
First Page PreviewforHeat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival | Full Text | References | PDF (449.3 KB) | Supplemental
  • 181 Views
  • 7 CrossRef citations
  • 0Altmetric
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
Heinz Ludwig, Meletios A. Dimopoulos, Philippe Moreau, Wee-Joo Chng, Hartmut Goldschmidt, Roman Hájek, Thierry Facon, Ludek Pour, Ruben Niesvizky, Albert Oriol, Laura Rosiñol, Aleksandr Suvorov, Gianluca Gaidano, Tomas Pika, Katja Weisel, Vesselina Goranova-Marinova, Antonio Palumbo, Heidi H. Gillenwater, Nehal Mohamed, Sanjay Aggarwal, Shibao Feng & Douglas Joshua
Pages: 2501-2504
Published online: 17 Mar 2017
First Page PreviewforCarfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup | Full Text | References | PDF (444.5 KB) | Supplemental
  • 1624 Views
  • 19 CrossRef citations
  • 0Altmetric
Association of GSTP1 inactivating polymorphism with acute myeloid leukemia and its specific chromosomal abnormalities
Aggeliki Daraki, Sophia Zachaki, Faidra Rosmaraki, Marina Kalomoiraki, Vassiliki Aleporou-Marinou, Constantina Sambani, Panagoula Kollia & Kalliopi N. Manola
Pages: 2505-2507
Published online: 02 Mar 2017
First Page PreviewforAssociation of GSTP1 inactivating polymorphism with acute myeloid leukemia and its specific chromosomal abnormalities | Full Text | References | PDF (300.4 KB) | Supplemental
  • 96 Views
  • 1 CrossRef citations
  • 0Altmetric
Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis
Abhishek Maiti, Nicholas J. Short, Srdan Verstovsek, Cynthia A. Powers, Cheryl A. Fullmer, Steven R. Reyes & Carlos E. Bueso-Ramos
Pages: 2508-2510
Published online: 28 Feb 2017
First Page PreviewforQuality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis | Full Text | References | PDF (292.6 KB) | Supplemental
  • 181 Views
  • 3 CrossRef citations
  • 0Altmetric
Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide
Satoko Oka, Kazuo Ono & Masaharu Nohgawa
Pages: 2511-2513
Published online: 28 Feb 2017
First Page PreviewforMyelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide | Full Text | References | PDF (881 KB) | Supplemental
  • 294 Views
  • 3 CrossRef citations
  • 0Altmetric
Lenalidomide-associated progressive multifocal leukoencephalopathy
Francesco Brigo, Elisabetta Pagani, Frediano Tezzon, Elisa Masi & Raffaele Nardone
Pages: 2514-2515
Published online: 21 Feb 2017
CitationforLenalidomide-associated progressive multifocal leukoencephalopathy | Full Text | References | PDF (375.2 KB) | Supplemental
  • 383 Views
  • 12 CrossRef citations
  • 0Altmetric

Correspondence

Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
Ahmet Emre Eskazan
Pages: 2516-2517
Published online: 28 Feb 2017
CitationforAdditional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia | Full Text | References | PDF (335.1 KB) | Supplemental
  • 181 Views
  • 0 CrossRef citations
  • 0Altmetric

Corrigendum

Correction
Correction to: Grzasko R, et al., Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group
Page: 2518
Published online: 09 Jun 2017
CitationforCorrection to: Grzasko R, et al., Chromosome 1 amplification has similar prognostic value to del(17p13) and t(4;14)(p16;q32) in multiple myeloma patients: analysis of real-life data from the Polish Myeloma Study Group | Full Text | PDF (94.3 KB)
  • 550 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles